9 Просмотры
Издатель
Nicotinamide has been shown to play an important role in DNA repair from UV damage. It has demonstrated benefits in protecting against nonmelanoma skin cancer and actinic keratoses, precancerous lesions. A study published in the New England Journal of Medicine found that oral nicotinamide at 500 mg twice daily for 12 months led to a reduction of 23% in the rate of new nonmelanoma skin cancers, basal cell carcinoma, and squamous cell carcinoma, development. There was also a noted reduction in the development of actinic keratoses. A study evaluating the impact of nicotinamide on protecting against both UVA and UVB damage on melanocytes, the cells that can form melanoma, found a protective effect in vitro. Talk to your Dermatologist to see if this is right for you.

FTC Disclaimer: This video is not sponsored. This page contains an affiliate link to products. I may receive a commission for purchases made through this link.

Disclaimer: This video is not intended to provide diagnosis, treatment, or medical advice. The content provided on this YouTube channel is for informational purposes only. Please consult with a physician or other healthcare professional regarding any medical or health-related diagnosis or treatment options. Information on this YouTube channel should not be considered as a substitute for advice from a healthcare professional. The statements made about specific products throughout this video are not to diagnose, treat, cure, or prevent disease.
Категория
Онкодерматология
Комментариев нет.